Palisade Bio Reports Positive PALI-2108 Phase 1b Clinical Data

Go back to Palisade Bio Reports Positive PALI-2108 Phase 1b Clinical Data
(NASDAQ: PALI) Delayed: 1.41 -0.13 (8.44%)
Previous Close $1.54    52 Week High $ 
Open $1.55    52 Week Low $ 
Day High $1.56    P/E N/A 
Day Low $1.40    EPS $ 
Volume 3,889,614